LORBRENA — PFIZER, approved 2026-01-29 (NDA210868).
5,165 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.